幹細胞アッセイの世界市場予測(~2021年)

◆英語タイトル:Stem Cell Assay Market by Type (Viability, Differentiation, Cell Identification), Kit (Mesenchymal, IPSCS, Hematopoietic), Product (Flow Cytometer, Detection Kit), Application (Regenerative Medicines, Drug Development), End User - Forecast to 2021
◆商品コード:MAM-BT-4628
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2016年10月7日
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥644,100見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、幹細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、製品別分析、用途別分析、地域別分析、幹細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global stem cell assay market is expected to reach USD 1,363.3 Million by 2021 from USD 536.6 Million in 2016, at a CAGR of 20.5% during the forecast period. Market growth can be attributed to the high prevalence of chronic diseases, increasing investment in research related activities, and technological advancements. However, stringent regulatory policies and high cost of stem cell based therapies are major factors restraining the growth of this market.
The global stem cell assay market has been segmented on the basis of type of assay, kit, detection, instrument, application, end-user, and region. On the basis of type of assay, the global market is segmented into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function and apoptosis. The viability/cytotoxicity segment is expected to be the largest and fastest-growing segment of the global market in 2016.; whereas, the isolation & purification segment is expected to grow at the highest CAGR during the forecast period.

The kit segment in the global stem cell assay market has been segmented into adult stem cell kits and human embryonic stem cell kits. The adult stem cell kits are segmented into mesenchymal stem cell kits, induced pluripotent stem cells kits (IPSCs), hematopoietic stem cell kits, umbilical cord stem cell kits and neuronal stem cells kits. Among the kit segment, the adult stem cell kits segment is projected to show the highest CAGR during the forecast period, 2016 to 2021. The high growth in this segment is due to the effectiveness of this type of kit in the analysis of cells.

Based on detection, the global stem cell assay market has been segmented into instruments and detection kits. The instrument segment is predicted to witness the highest CAGR from 2016 to 2021. The high growth in this segment is associated with the rising demand for instruments from research and medical services.

Based on the instruments, the market is segmented into flow cytometer, micro electrode arrays, cell imaging systems and automated cell counter. The flow cytometer segment is anticipated to witness the highest growth rate from 2016 to 2021. The high growth rate of this segment can be attributed to its increased demand for cell analysis in industrial research.

North America dominates the global market in 2016, owing to the increasing incidence and prevalence of chronic diseases and increasing patient pool in North American countries. However, the RoW region is expected to witness the highest CAGR during the forecast period. The high growth in this segment is centered in Latin America, the Middle East, and Africa owing to the increased adoption of stem cell based therapies in these regions.

The major players in the stem cell assay market are include GE Healthcare (U.K.), Promega Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Cell Biolabs, Inc. (U.S.), Hemogenix Inc. (U.S.), STEMCELL Technologies Inc. (CA), Bio-Rad Laboratories, Inc. (U.S.), Bio-Techne Corporation (U.S.), and Cellular Dynamics International, Inc. (U.S.).

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 27)
4.1 Lucrative Opportunities in the Global Stem Cells Market
4.2 Regional Analysis: Stem Cell Assay Market, By Kits, 2016

5 Market Overview (Page No. – 30)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Stem Cell Assay Market Segmentation, Assay Types
5.2.2 Stem Cell Assay Market Segmentation, By Kits
5.2.3 Stem Cell Assay Market Segmentation, By Application
5.2.4 Stem Cell Assay Market Segmentation, By End User
5.2.5 Stem Cell Assay Market Segmentation, By Region
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Investment in Research Related Activities
5.3.1.2 Technological Advancements
5.3.1.3 Funding for Stem Cell Research
5.3.2 Restraints
5.3.2.1 Affordability of Stem Cell Therapies & Treatments
5.3.2.2 Slow Response Time of Regulatory Bodies & Training Needs
5.3.3 Opportunities
5.3.3.1 Evolving Market & Fast Changing Market Dynamics
5.3.4 Challenges
5.3.4.1 Unapproved Stem Cell Operations

6 Stem Cell Assay Market, By Technology (Page No. – 38)
6.1 Introduction
6.1.1 Technology Roadmap
6.1.2 Figure 1.1 Stem Cell Assay Market, By Technology
6.1.3 Micro Fabricated Assisted Technology
6.1.3.1 Microfluidics Based Cell Trap Technologies
6.1.4 Technology in Development

7 Stem Cell Assay Market, By Assay (Page No. – 44)
7.1 Introduction
7.1.1 Cell Viability & Toxicity Assays
7.1.2 Isolation/Purification Assays
7.1.3 Cell Identification Assays
7.1.4 Cell Proliferation Assays
7.1.5 Cell Differentiation Assays
7.1.6 Cell Function Assays
7.1.7 Cell Apoptosis Assays

8 Stem Cell Assay Market, By Kits (Page No. – 56)
8.1 Introduction
8.2 Adult Stem Cell Kits
8.2.1 Mesenchymal Stem Cell Kits
8.2.2 Induced Pluripotent Stem Cell Kits
8.2.3 Hematopoietic Stem Cell Kits
8.2.4 Neuronal Stem Cells Kits
8.2.5 Umbilical Cord Stem Cells
8.3 Human Embryonic Stem Cells Kits

9 Stem Cell Assay Market, By Product (Page No. – 69)
9.1 Introduction
9.2 Figure 1.1 Stem Cell Assay Market, By Product
9.3 Instruments
9.3.1 Micro Electrode Arrays
9.3.2 Flow Cytometer
9.3.3 Cell Imaging Systems
9.3.4 Automated Cell Counter
9.4 Detection Kits
9.4.1 Immuno Histochemistry Kits

10 Stem Cell Assays Market, By Application (Page No. – 80)
10.1 Introduction
10.2 Regenerative Medicine & Therapy Development
10.2.1 Orthopedic & Musculoskeletal Spine
10.2.2 Dermatology
10.2.3 Cardiovascular
10.2.4 Central Nervous System
10.2.5 Oncology
10.2.6 Diabetes
10.2.7 Others
10.3 Drug Discovery and Development
10.4 Clinical Research

11 Stem Cell Assays, By End User (Page No. – 97)
11.1 Introduction
11.2 Research Institutes
11.3 Industry Research

12 Regional Analysis (Page No. – 103)
12.1 Introduction
12.2 North America
12.3 Europe
12.4 Asia-Pacific
12.5 Rest of the World (RoW)

13 Competitive Landscape (Page No. – 146)
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Situation and Trends
13.3.1 Approvals
13.3.2 Agreements, Partnerships & Collaborations
13.3.3 Acquisitions
13.3.4 Expansions
13.3.5 Other Developments

14 Company Profiles (Page No. – 152)
14.1 Introduction
14.2 GE Healthcare
14.2.1 Business Overview
14.2.2 Company Snapshot GE Healthcare
14.2.3 Product Portfolio
14.2.4 Recent Developments
14.2.5 MnM View
14.3 Promega Corporation
14.3.1 Business Overview
14.3.2 Company Snapshot: Promega Corporation
14.3.3 Product Portfolio
14.3.4 Recent Developments
14.3.5 MnM View
14.4 Thermo Fisher Scientific Pvt. Ltd
14.4.1 Business Overview
14.4.2 Company Snapshot: Thermo Fisher Scientific
14.4.3 Product Portfolio
14.4.4 Recent Developments
14.4.5 MnM View
14.5 Merck Millipore
14.5.1 Business Overview
14.5.2 Company Snapshot: Merck Millipore
14.5.3 Product Portfolio
14.5.4 Recent Developments
14.5.5 MnM View
14.6 Cell Bio Labs, Inc.
14.6.1 Business Overview
14.6.2 Product Portfolio
14.6.3 Recent Developments
14.6.4 MnM View
14.7 Hemogenix Inc.
14.7.1 Business Overview
14.7.2 Product Portfolio
14.7.3 Recent Developments
14.7.4 MnM View
14.8 Stem Cell Technologies
14.8.1 Business Overview
14.8.2 Product Portfolio
14.8.3 Recent Developments
14.8.4 MnM View
14.9 Bio Rad
14.9.1 Business Overview
14.9.2 Company Snapshot: Bio Rad
14.9.3 Product Portfolio
14.9.4 Recent Developments
14.9.5 MnM View
14.10 R&D Systems
14.10.1 Business Overview
14.10.2 Company Snapshot: R&D Sysytems
14.10.3 Product Portfolio
14.10.4 MnM View
14.11 Cellular Dynamics International.
14.11.1 Business Overview
14.11.2 Product Portfolio
14.11.3 Recent Developments
14.11.4 MnM View

15 Appendix (Page No. – 175)
15.1 Insights From Industry Experts
15.2 Discussion Guide
15.3 Introducing RT: Real-Time Market Intelligence
15.4 Available Customizations
15.5 Related Reports

List of Tables (73 Tables)

Table 1 Global Stem Cell Assay Market By Assat Types 2014 –2021 (USD Million)
Table 2 Cell Viability/Cytotoxicity Assay Market Size, By Region, 2014–2021 (USD Million)
Table 3 Isolation/Purification Assay Market Size, By Region, 2014–2021 (USD Million)
Table 4 Cell Identification Assay Market Size, By Region, 2014–2021 (USD Million)
Table 5 Cell Proliferation Assay Market Size, By Region, 2014–2021 (USD Million)
Table 6 Cell Differentiation Assay Market Size, By Region, 2014–2021 (USD Million)
Table 7 Cell Function Assay Market Size, By Region, 2014–2021 (USD Million)
Table 8 Cell Apoptosis Market Size, By Region, 2014–2021 (USD Million)
Table 9 Global Market Size, By Kits, 2014–2021 (USD Million)
Table 10 Global Adult Stem Cell Kits Market Size, By Types, 2014–2021 (USD Million)
Table 11 Mesenchymal Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 12 Induced Pluripotent Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 13 Hematopoietic Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 14 Neuronal Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 15 Umbilical Cord Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 16 Human Embryonic Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 17 Stem Cell Assay Product Market Size, By Product, 2014–2021 (USD Million)
Table 18 Stem Cell Assay Product Market Size, By Instruments, 2014–2021 (USD Million)
Table 19 Micro Electrode Arrays Market Size, By Region, 2014–2021 (USD Million)
Table 20 Flow Cytometer Market Size, By Region, 2014–2021 (USD Million)
Table 21 Cell Imaging Market Size, By Region, 2014–2021 (USD Million)
Table 22 Automated Cell Counter Market Size, By Region, 2014–2021 (USD Million)
Table 23 Detection Kits Market Size, By Region, 2014–2021 (USD Million)
Table 24 Market Size, By Application, 2014–2021 (USD Million)
Table 25 Regenerative Medicine & Therapy Development Market Size, By Region, 2014–2021 (USD Million)
Table 26 Regenerative Medicine & Therapy Development Market Size, By Application, 2014–2021 (USD Million)
Table 27 Orthopaedic & Musculoskeleton Spine Market Size, By Region, 2014–2021 (USD Million)
Table 28 Dermatology Market Size, By Region, 2014–2021 (USD Million)
Table 29 Cardiovascular Market Size, By Region, 2014–2021 (USD Million)
Table 30 Central Nervous System Market Size, By Region, 2014–2021 (USD Million)
Table 31 Oncology Market Size, By Region, 2014–2021 (USD Million)
Table 32 Diabetes Market Size, By Region, 2014–2021 (USD Million)
Table 33 Others Market Size, By Region, 2014–2021 (USD Million)
Table 34 Others Market Size, By Region, 2014–2021 (USD Million)
Table 35 Others Market Size, By Region, 2014–2021 (USD Million)
Table 36 Market Size, By End User, 2014–2021 (USD Million)
Table 37 Market Size for Research Institutes, By Region, 2014–2021 (USD Million)
Table 38 Market Size for Research Institutes, By Region, 2014–2021 (USD Million)
Table 39 Market Size, By Region, 2014–2021 (USD Million)
Table 40 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 41 North America: Market Size, By Assay Type, 2014–2021 (USD Million)
Table 42 North America: Market Size, By Kits, 2014–2021 (USD Million)
Table 43 North America: Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Table 44 North America: Market Size, By Detection, 2014–2021 (USD Million)
Table 45 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 46 North America: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application 2014–2021 (USD Million)
Table 47 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 48 Viability/Cytotoxicity Type Expected to Lead the European Market,By Type in 2016
Table 49 Europe Market Size, By Assay Type, 2014–2021 (USD Million)
Table 50 Europe: Market Size, By Kits, 2014–2021 (USD Million)
Table 51 Europe: Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Table 52 Europe: Market Size, By Detection, 2014–2021 (USD Million)
Table 53 Europe Market Size, By Application, 2014–2021 (USD Million)
Table 54 Europe: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application 2014–2021 (USD Million)
Table 55 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 56 Asia Pacific: Market Size, By Assay Type, 2014–2021 (USD Million)
Table 57 Asia Pacific: Market Size, By Kits, 2014–2021 (USD Million)
Table 58 Asia Pacific: Stem Cell Market Size, By Kits Under Adult Stem Cell Kits, 2014–2021 (USD Million)
Table 59 North America: Market Size, By Detection, 2014–2021 (USD Million)
Table 60 Asia Pacific: Market Size, By Application, 2014–2021 (USD Million)
Table 61 Asia Pacific: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application 2014–2021 (USD Million)
Table 62 Asia Pacific: Market Size, By End User, 2014–2021 (USD Million)
Table 63 Rest of the World: Market Size, By Assay Type, 2014–2021 (USD Million)
Table 64 Rest of the World: Market Size, By Kits, 2014–2021 (USD Million)
Table 65 Rset of the World : Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Table 66 Rest of the World: Market Size, By Detection, 2014–2021 (USD Million)
Table 67 Rest of the World: Market Size, By Application, 2014–2021 (USD Million)
Table 68 Rest of the World: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application 2014–2021 (USD Million)
Table 69 Rest of the World: Market Size, By End User, 2014–2021 (USD Million)
Table 70 Approvals, 2013–2016
Table 71 Agreements, Partnerships & Collaborations, 2013–2016
Table 72 Acquisitions, 2013–2016
Table 73 Expansions, 2013–2016


List of Figures (93 Figures)

Figure 1 Market Segmentation
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Global Market, By Type, 2016 vs 2021 (USD Million)
Figure 8 Global Market By Kits Segment 2016 vs 2021
Figure 9 Global Market By End 2016-2021
Figure 10 North America Led the Global Market in 2016
Figure 11 Global Stem Cells Assays Market to Witness High Growth During the Forecast Period
Figure 12 Mesenchymal Stem Cell Kits Dominated the Global Market, 2016
Figure 13 Viability/Cytotxicity Assay Market to Witness the Fastest Growth During the Forecast Period in the Market
Figure 14 North America to Witness the Fastest Growth During the Forecast Period
Figure 15 Market Segmentation
Figure 16 Market Segmentation, By Application
Figure 17 Market Segmentation, By End User
Figure 18 Market Segmentation, By Region
Figure 19 Drivers, Restraints, Opportunities, and Challenges
Figure 20 Global Market By Assat Types 2016 –2021 (USD Million)
Figure 21 North America to Account the Largest Share in Cell Viability/Toxicity Assay Market in 2016
Figure 22 North America to Account the Largest Share in Isolation/Purification Assay Market in 2016
Figure 23 North America to Account the Largest Share in Cell Identification Assay Market in 2016
Figure 24 North America to Account the Largest Share in Cell Proliferation Assay Market in 2016
Figure 25 North America to Account the Largest Share in Cell Differentiation Assay Market in 2016
Figure 26 North America to Account the Largest Share in Cell Function Assay Market in 2016
Figure 27 North America to Account the Largest Share in Cell Apoptosis Assay Market in 2016
Figure 28 Global Stem Cell Assay Market, By Kits, 2016 & 2021 (USD Million)
Figure 29 Global Adult Stem Cell Kits Market Size, By Types, 2014–2021 (USD Million)
Figure 30 North America to Account the Largest Share in Mesenchymal Stem Cell Kits Market in 2016
Figure 31 North America to Account the Largest Share in Induced Pluripotent Stem Cell Kits Market in 2016
Figure 32 North America to Account the Largest Share in Hematopoietic Stem Cell Kits Market in 2016
Figure 33 North America to Account the Largest Share in Neuronal Stem Cell Kits Market in 2016
Figure 34 North America to Account the Largest Share in Umbilical Cord Stem Cell Kits Market in 2016
Figure 35 North America to Account the Largest Share in Human Embryonic Stem Cell Kits Market in 2016
Figure 36 The Instrument Market Led the Stem Cell Assay By Product Market in 2015
Figure 37 Flow Cytometer Led the Stem Cell Assay By Instruments Market in 2016
Figure 38 North America Accounted for the Largest Share of the Micro Electrode in Stem Cell Assay By Product in 2016
Figure 39 North America Accounted for the Largest Share of the Flow Cytometer in Stem Cell Assay By Product in 2016
Figure 40 North America Accounted for the Largest Share of the Cell Imaging Systems in Stem Cell Assay By Product in 2016
Figure 41 North America Accounted for the Largest Share of the Automated Cell Counter in Stem Cell Assay By Product in 2016
Figure 42 North America Accounted for the Largest Share of the Detection Kits in Stem Cell Assay By Product in 2016
Figure 43 Regenerative Medicine & Therapy Development Market to Dominate the Stem Cell Assays Application Market in 2016
Figure 44 Regenerative Medicine & Therapy Development Market Size, By Region, 2014–2021 (USD Million)
Figure 45 Regenerative Medicine & Therapy Development Market Segmentation, By Application
Figure 46 Orthopaedic & Musculoskeleton Spine to Dominate the Regenerative Medicines Application Market in 2016
Figure 47 North America to Command the Largest Share of the Regenerative Medicine & Therapy Development Market for Orthopedic & Musculoskeletal Spine in 2016
Figure 48 North America to Dominate the Regenerative Medicines Market for Dermatology in 2016
Figure 49 North America is the Fastest Growing Region in the Regenerative Medicines Market for Cardiovascular Applications in 2016
Figure 50 North America to Dominate the Regenerative Medicine & Therapy Development Market for Central Nervous System Applications in 2016
Figure 51 North America is the Fastest Growing Region in the Regenerative Medicine & Therapy Development Market for Oncology Application
Figure 52 North America is the Fastest Growing Region in the Regenerative Medicine & Therapy Development Market for Diabetes Application
Figure 53 North America to Dominate the Regenerative Medicine & Therapy Development Market for Others Applications in 2016
Figure 54 North America to Dominate the Drug Discovery and Development Market in 2016
Figure 55 North America to Dominate the Clinical Research Market in 2016
Figure 56 Market Size, By End User, 2016 (USD Million)
Figure 57 North America to Dominate the Market for Research Institutes Between 2016 and 2021
Figure 58 North America to Dominate the Market for Industry Research Between 2016 and 2021
Figure 59 Market in North America to Grow at the Fastest Rate During the Forecast Period
Figure 60 North America: Market Snapshot
Figure 61 Viability/Cytotoxicity Type Expected to Lead the North American Market, in 2016
Figure 62 The Adult Stem Cell Kits are Expected to Dominate the North American Market, By Kits in 2016
Figure 63 North America Stem Cell Market Size, By Adult Stem Cell Kits, 2016–2021
Figure 64 Instruments to Dominate the North American Stem Cell Assay Detection Market in 2016
Figure 65 The Regenerative Medicine & Therapy Development to Dominate the North American Stem Cell Assay Market, By Application in 2016
Figure 66 North America: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application, 2014–2021 (USD Million)
Figure 67 Industry Research is Estimated to Form the Largest Segment in the North American Stem Cell Assay Market, By End User in 2016
Figure 68 Europe: Stem Cell Assay Market Snapshot
Figure 69 Europe: Stem Cell Assay Market Size, By Country, 2014–2021 (USD Million)
Figure 70 The Adult Stem Cell Kits are Expected to Dominate the Europe Stem Cell Assay Market, By Kits in 2016
Figure 71 Europe: Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Figure 72 Instruments to Dominate the Europe Stem Cell Assay Market,By Detection in 2016
Figure 73 The Regenerative Medicine & Therapy Development to Dominate the North American Stem Cell Assay Market, By Application in 2016
Figure 74 Europe: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application, 2014–2021 (USD Million)
Figure 75 Industry Research to Account for the Largest Share of the Stem Cell Assay End User Market in Europe
Figure 76 Asia-Pacific Stem Cell Assay Market Snapshot
Figure 77 Viability/Cytotoxicity Assay Expected to Lead the North American Stem Cell Assay Market,By Type in 2016
Figure 78 The Adult Stem Cell Kits are Expected to Dominate the Asia-Pacific Stem Cell Assay Market, By Kits in 2016
Figure 79 Asia Pacific: Stem Cell Market Size, By Kits Under Adult Stem Cell Kits, 2014–2021 (USD Million)
Figure 80 Instruments to Dominate the North American Stem Cell Assay Market,By Detection in 2016
Figure 81 The Regenerative Medicine & Therapy Development to Dominate the Asia Pacific Stem Cell Assay Market, By Application in 2016
Figure 82 Asia Pacific: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application, 2014–2021 (USD Million)
Figure 83 Industry Research is Estimated to Form the Largest Segment in the North American Stem Cell Assay Market, By End User in 2016
Figure 84 Viability/Cytotoxicity Type Expected to Lead the Rest of the World Stem Cell Assay Market, By Type in 2016
Figure 85 The Adult Stem Cell Kits are Expected to Dominate the Rest of the World Stem Cell Assay Market, By Kits in 2016
Figure 86 Rest of the World: Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Figure 87 Instruments to Dominate the Rest of the World Stem Cell Assay Market, By Detection in 2016
Figure 88 The Regenerative Medicine & Therapy Development to Dominate the Rest of the World Stem Cell Assay Market, By Application in 2016
Figure 89 Rest of the World: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application, 2014–2021 (USD Million)
Figure 90 Industry Research is Estimated to Form the Largest Segment in the Rest of the World Stem Cell Assay Market, By End User in 2016
Figure 91 Companies Adopted Approvals as Their Key Growth Strategy Over the Last Three Years
Figure 92 Global Stem Cell Assay Market Share, By Key Player, 2015
Figure 93 Approvals: the Key Growth Strategy Adopted By Market Players From 2013 to 2015

【レポートのキーワード】

幹細胞アッセイ、細胞識別アッセイ、細胞増殖アッセイ、細胞アポトーシス、幹細胞アッセイキット、フローサイトメーター、幹細胞アッセイ装置

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[幹細胞アッセイの世界市場予測(~2021年)]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月05日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆